Skip to main content
DAVEW logo

DAVEW · Dave Inc. · Debt

Track DAVEW — free
$1.47 -0.01 (-0.68%) At close · Oct 21
Market Cap
$4.81B
Shares
12.76M
Volume · Oct 21 44.74K Avg daily vol (3M) 32K

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current operating lease liabilities 2026-06-30 USD 227,000 10-Q filed 2026-08-05
Current portion of line of credit borrowings 2026-06-30 USD 75,000,000 10-Q filed 2026-08-05
Noncurrent convertible debt 2026-06-30 USD 193,134,000 10-Q filed 2026-08-05
Noncurrent operating lease liabilities 2026-06-30 USD 106,000 10-Q filed 2026-08-05
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
1 filing has incomplete source or extraction coverage. Verified observations are shown; missing observations do not establish that debt was unchanged.

Covenants

Some sections could not be verified in 1 agreement document. Other restrictions or tests may apply.

Verified tests, triggers and restrictions appear with each agreement below. A verified term does not establish current compliance.

Loans, facilities and notes

0% Convertible Senior Notes due 2031

Note · Dave Inc.

Reference: 0% Convertible Senior Notes due 2031

Active
Original principal
USD 200,000,000
Outstanding
—
Commitment
—
Availability
—
Maturity
—

Last reported interest terms: 0% Reported 2026-03-09 Later filings may not restate these terms; this does not confirm they still apply.

Verified covenant terms

  • Section 14.07(c) · Effect of Recapitalizations, Reclassifications and Changes of the Common Stock The Company shall not become a party to any Share Exchange Event unless its terms are consistent with this Section 14.07. Applies to every series under this agreement Section 14.07. Effect of Recapitalizations, Reclassifications and Changes of the Common Stock.
    Full wording and supporting evidence
    Source evidence: (c) The Company shall not become a party to any Share Exchange Event unless its terms are consistent with this Section 14.07.
    Target identity evidence: INDENTURE dated as of March 9, 2026 between DAVE INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
    Target identity evidence: WHEREAS, for its lawful corporate purposes, the Company has duly authorized the issuance of its 0% Convertible Senior Notes due 2031 (the “Notes”), initially in an aggregate principal amount not to exceed $200,000,000, and in order to provide the terms and conditions upon which the Notes are to be authenticated, issued and delivered, the Company has duly authorized the execution and delivery of this Indenture; and
Documents and filing history
  1. Issuance · 2026-03-09 Original principal USD 200,000,000 Exact source document Parent 8-K filing · 2026-03-09
    This Note is one of a duly authorized issue of Notes of the Company, designated as its 0% Convertible Senior Notes due 2031 (the “**Notes**”), limited to the aggregate principal amount of $200,000,000 all issued or to be issued under and pursuant to an Indenture dated as of March 9, 2026 (the “**Indenture**”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “**Trustee**”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Notes. Additional Notes may be issued in an unlimited aggregate principal amount, subject to certain conditions specified in the Indenture. Capitalized terms used in this Note and not defined in this Note shall have the respective meanings set forth in the Indenture.
    Issuer evidence: INDENTURE dated as of March 9, 2026 between DAVE INC., a Delaware corporation, as issuer (the “Company,” as more fully set forth in Section 1.01), and U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee,” as more fully set forth in Section 1.01).
    Supporting evidence: This Note is one of a duly authorized issue of Notes of the Company, designated as its 0% Convertible Senior Notes due 2031 (the “**Notes**”), limited to the aggregate principal amount of $200,000,000 all issued or to be issued under and pursuant to an Indenture dated as of March 9, 2026 (the “**Indenture**”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “**Trustee**”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Notes. Additional Notes may be issued in an unlimited aggregate principal amount, subject to certain conditions specified in the Indenture. Capitalized terms used in this Note and not defined in this Note shall have the respective meanings set forth in the Indenture.
    Supporting evidence: This Note is one of a duly authorized issue of Notes of the Company, designated as its 0% Convertible Senior Notes due 2031 (the “**Notes**”), limited to the aggregate principal amount of $200,000,000 all issued or to be issued under and pursuant to an Indenture dated as of March 9, 2026 (the “**Indenture**”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “**Trustee**”), to which Indenture and all indentures supplemental thereto reference is hereby made for a description of the rights, limitations of rights, obligations, duties and immunities thereunder of the Trustee, the Company and the Holders of the Notes. Additional Notes may be issued in an unlimited aggregate principal amount, subject to certain conditions specified in the Indenture. Capitalized terms used in this Note and not defined in this Note shall have the respective meanings set forth in the Indenture.
Key facts CIK 1841408 CUSIP 23834J201 Visit website Investor relations